https://www.selleckchem.com/pr....oducts/imidazole-ket
Background We aimed to provide personalized risk estimates for cardiac events (CEs) and life-threatening events in women with either type 1 or type 2 long QT. Methods and Results The prognostic model was derived from the Rochester Long QT Syndrome Registry, comprising 767 women with type 1 long QT (n=404) and type 2 long QT (n=363) from age 15 through 60 years. The risk prediction model included the following variables genotype/mutation location, QTc-specific thresholds, history of syncope, and β-blocker therapy. A mode
Like
Comment
Share
